Description :
Galvus Met is a combination antidiabetic medicine containing Vildagliptin (50mg) and Metformin (1000mg). It is used to manage type 2 diabetes mellitus in adults, especially when blood sugar cannot be adequately controlled with diet, exercise, or metformin alone.
Vildagliptin (a DPP-4 inhibitor) enhances insulin release and lowers glucagon secretion.
Metformin improves insulin sensitivity and reduces glucose production in the liver.
Together, they provide better glycemic control and help reduce the risk of diabetes-related complications.
---
Dosage:
Adults: Usually 1 tablet twice daily (morning and evening) with meals, to reduce stomach upset.
Maximum dosage should be determined by a healthcare professional.
Side Effects:
Common:
Nausea, diarrhea, indigestion
Headache, dizziness
Upper respiratory tract infections
Serious (seek medical help):
Lactic acidosis (rare but serious; symptoms include muscle pain, weakness, difficulty breathing)
Liver dysfunction (jaundice, dark urine)
Severe allergic reactions
---
Warnings & Precautions:
Not for patients with type 1 diabetes or diabetic ketoacidosis.
Avoid in severe kidney or liver impairment.
Use with caution in elderly patients.
Avoid alcohol as it increases the risk of lactic acidosis.
Regular monitoring of blood sugar, kidney, and liver function is recommended.
